Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
Jazyk angličtina Země Dánsko Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
001
World Health Organization - International
CINTESIS@RISE, Porto, Portugal
ARIA (Allergic Rhinitis and its Impact on Asthma), Montpellier, France
Fraunhofer-Institut für Translationale Medizin und Pharmakologie
PubMed
41268627
PubMed Central
PMC12862529
DOI
10.1111/all.70100
Knihovny.cz E-zdroje
- Klíčová slova
- ENT (rhinitis, sinusitis, nasal polyps…), allergic rhinitis, asthma, guidelines,
- MeSH
- alergická rýma * terapie diagnóza MeSH
- algoritmy * MeSH
- bronchiální astma * terapie diagnóza MeSH
- klinické rozhodování MeSH
- lidé MeSH
- management nemoci MeSH
- medicína založená na důkazech MeSH
- sdílené rozhodování * MeSH
- směrnice pro lékařskou praxi jako téma * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines produced their first edition in 1999, with subsequent revisions in 2008, 2010, 2016 and 2019. A new iteration of ARIA-ARIA 2024-2025-in collaboration with EAACI is currently being developed, focusing on the management of allergic rhinitis. ARIA 2024-2025 follows the GRADE framework and is endorsed by the European Academy of Allergy and Clinical Immunology (EAACI). A set of approaches has been used to develop guideline questions, including surveying key opinion leaders and using artificial intelligence (AI)-based tools to analyse web searches on allergic rhinitis and to generate questions. Each prioritised guideline question is assessed through an Evidence-to-Decision (EtD) framework. EtDs support the systematic and transparent formulation of recommendations, comprising 12 criteria for which the best available evidence should be sought. In the context of ARIA-EAACI 2024-2025, such evidence is derived not only from randomised controlled trials but also-among others-from patient-generated data sources that better reflect the affected individuals' perspectives. Moreover, ARIA-EAACI 2024-2025 incorporates evidence on planetary health. Developed guideline recommendations will support the creation of digitalised decision algorithms and care pathways. This paper describes the methodology used to develop the person-centred, digitally enabled and AI-assisted ARIA-EAACI 2024-2025. Among others, it describes (i) the development and prioritisation of guideline questions, (ii) sources of evidence for EtDs and (iii) the development of digitalised decision algorithms and care pathways.
Adult Allergy and Immunology Division Hamad Medical Corporation Doha Qatar
Al Sham Private University Damascus Syria
Allergist David Tvildiani Medical University Tbilisi Georgia
Allergist Private Practice Mexico City Mexico
Allergy and Asthma Medical Director CLINICA SISUL FACAAI SPAAI Asuncion Paraguay
Allergy and Clinical Immunology Department University Hospital Center Mother Teresa Tirana Albania
Allergy and Clinical Immunology Unit Mauriziano Hospital Torino Italy
Allergy and Clinical Immunology University of Bari Medical School Bari Italy
Allergy and Immunology Centre Pantai Hospital Kuala Lumpur Kuala Lumpur Malaysia
Allergy Center CUF Descobertas Hospital Lisbon Portugal
Allergy Department 2nd Pediatric Clinic National and Kapodistrian University of Athens Athens Greece
Allergy Section Department of Internal Medicine Hospital Vall D'hebron Barcelona Spain
Allergy Service Fundacion Jimenez Diaz Autonoma University of Madrid CIBERES ISCIII Madrid Spain
Allergy Service University Hospital Professor Polydoro Ernani de São Thiago Florianópolis Brazil
Allergy Unit Department of Internal Medicine University Hospital AOU delle Marche Ancona Italy
Allergy Unit Instituto and Hospital CUF Porto Portugal
Allergy Unit Málaga Regional University Hospital of Málaga Malaga University ARADyAL Malaga Spain
Allergy Unit Meyer Children's Hospital IRCCS Florence Italy
ARADyAL Research Network Barcelona Spain
ARIA Asthma Rhinitis Immunology and Allergy Department Athens Greece
Asthma and Allergy Unit IRCCS Humanitas Research Hospital Rozzano Milan Italy
Asthma COPD Outpatient Care Unit University Medical Center Hô Chi Minh Vietnam
Barcelona Institute for Global Health Barcelona Spain
BIOS S p A Società Benefit Rome Italy
Casa di Cura Villa Montallegro Allergology Department Genova Italy
Center Allergy and Immunology and Geomedi Teaching University Faculty of Medicine Tbilisi Georgia
Center for Molecular Medicine Karolinska University Hospital Stockholm Sweden
Center for Rhinology and Allergology Allergology and Rhinology Department Wiesbaden Germany
Center of Allergy Immunology and Respiratory Diseases Santa Fe Argentina
Charles University Prague Czech Republic
Chiba Rosai Hospital ENT Department Chiba Japan
Chiba University Hospital Department of Otolaryngology Head and Neck Surgery Chiba Japan
CHRC LA REAL NOVA Medical School NMS Universidade NOVA de Lisboa Lisboa Portugal
CIBER Epidemiología y Salud Pública Barcelona Spain
Clinic of Allergology and Immunology University Clinical Center of Serbia Belgrade Serbia
Clinic of Asthma Allergy and Chronic Lung Diseases Asthma and Allergy Department Vilnius Lithuania
Clinic of Occupational Diseases University Hospital Sveti Ivan Rilski Sofia Bulgaria
Clinical Management Group Woolcock Institute of Medical Research Sydney Australia
Clinique des Bronches Allergie et Sommeil Hôpital Nord Marseille France
Comenius University Bratislava Slovakia
CRESS Inserm INRAE HERA Team Paris Cité University Paris France
Croatian Pulmonary Society Clinical Center for Pulmonary Diseases Zagreb Croatia
Department for Otorhinolaryngology Head and Neck Surgery University of Tübingen Tübingen Germany
Department of Allergology and Internal Medicine Medical University of Bialystok Byalistok Poland
Department of Allergology Medical University of Gdansk Gdansk Poland
Department of Allergology Medical University of Gdańsk Gdańsk Poland
Department of Allergy and Clinical Immunology Air Force General Hospital Athens Greece
Department of Allergy and Immunology Hospital Quironsalud Bizkaia Bilbao Spain
Department of Allergy and Immunology Para State University Center CESUPA Belém Brazil
Department of Allergy Clinics Hospital National University San Lorenzo Paraguay
Department of Allergy Hospital La Paz Institute for Health Research Madrid Spain
Department of Biomedical Science Humanitas University Pieve Emanuele Milan Italy
Department of Clinical and Molecular Sciences Marche Polytechnic University Ancona Italy
Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Sweden
Department of Health Sciences University of Florence Florence Italy
Department of Immunoallergology Cova da Beira University Hospital Centre Covilhã Portugal
Department of Immunology and Allergology Lithuanian University of Health Sciences Kaunas Lithuania
Department of Internal Medicine Federal University of Santa Catarina Florianópolis Brazil
Department of Internal Medicine University of Genoa Genoa Italy
Department of Internal Medicine University of Medicine Tirana Albania
Department of Lung Diseases and Clinical Immunology University of Turku Turku Finland
Department of Medical Sciences University of Turin Turin Italy
Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China
Department of Medicine Faculty of Medicine and Surgery University of Malta MSD Msida Malta
Department of Medicine Federal University of Pampa Uruguaiana Brazil
Department of Otolaryngology Head and Neck Surgery Eye and Ear University Hospital Beirut Lebanon
Department of Otolaryngology Head and Neck Surgery Johns Hopkins University Baltimore Maryland USA
Department of Otolaryngology Head and Neck Surgery Universitätsmedizin Mainz Mainz Germany
Department of Otorhinolaryngology Charité Universitätsmedizin Berlin Berlin Germany
Department of Otorhinolaryngology Chiba University Chiba Japan
Department of Otorhinolaryngology Head and Neck Surgery Dar Al Shifa Hospital Salmiya Kuwait
Department of Otorhinolaryngology Head and Neck Surgery Semmelweis University Budapest Hungary
Department of Pediatrics Medical College of Georgia at Augusta University Augusta Georgia USA
Department of Pediatrics Medical School Federal University of Minas Gerais Belo Horizonte Brazil
Department of Pediatrics Nippon Medical School Tokyo Japan
Department of Political Science University of Zürich Zürich Switzerland
Department of Primary Care and Population Health University of Nicosia Medical School Nicosia Cyprus
Department of Pulmonary Diseases Celal Bayar University Faculty of Medicine Manisa Turkey
Department of Pulmonary Medicine Mainz University Hospital Mainz Germany
Department of Pulmonology and Allergology Klaipeda National Hospital Klaipeda Lithuania
Department of Respiratory Medicine and Tuberculosis University Hospital Brno Czech Republic
Department of Respiratory Medicine Copenhagen University Hospital Hvidovre Copenhagen Denmark
Department of Respiratory Medicine JSS Medical College JSSAHER Mysore Karnataka India
Department of Women's and Children's Health Paediatric Research Uppsala University Uppsala Sweden
Division of Allergy Asthma and Clinical Immunology Emek Medical Center Afula Israel
Division of Allergy Immunology University of South Florida Tampa Florida USA
Dr Agostinho Neto University Hospital Epidemiology Department Praia Cabo Verde
Ecole Polytechnique de Palaiseau Palaiseau France
ENT and Allergology Düsseldorf Germany
ENT Department University Hospital of Kinshasa Kinshasa Democratic Republic of Congo
Faculty of Health Sciences Catholic University of Salta Salta Argentina
Faculty of Health University of Plymouth Plymouth UK
Faculty of Medicine University of Belgrade Belgrade Serbia
Faculty of Medicine University of Ljubljana Ljubljana Slovenia
Faculty of Medicine University of Southampton Southampton UK
Faculty of Public Health Sofia Medical University Sofia Bulgaria
FiLHA Finnish Lung Health Association Helsinki Finland
Finnish Meteorological Institute Helsinki Finland
French National Reference Center for Angioedema Saint Antoine University Hospital Paris France
Fundaçao ProAR and Universidade Federal da Bahia Salvador Bahia Brazil
Global NCD Platform Geneva Switzerland
Head of Laboratory of Atmospheric Processes and Aerobiology University of Latvia Riga Latvia
Immunology and Allergy Division Clinical Hospital University of Chile Santiago Chile
Immunology Cabo Verde University Faculty of Medicine Praia Cape Verde
Imperial College Healthcare NHS Trust London UK
Inserm Equipe d'Epidémiologie Respiratoire Intégrative CESP Villejuif France
Inserm Équipe d'Epidémiologie Respiratoire Intégrative Villejuif France
Institute of Clinical Medicine Children's Clinic Tartu University Tartu Estonia
Institute of Clinical Medicine University of Copenhagen Copenhagen Denmark
Institute of Immunology Faculty of Medicine University of Coimbra Coimbra Portugal
Institute of Sciences of Food Production National Research Council Bari Italy
Institute of Translational Pharmacology Palermo Italy
International Primary Care Respiratory Group IPCRG Aberdeen UK
International Primary Care Respiratory Group IPCRG Edinburgh UK
IRCCS Humanitas Research Center Personalized Medicine Asthma and Allergy Rozzano Milan Italy
ISGlobal Barcelona Institute for Global Health Barcelona Spain
Japan Antituberculosis Association Fukujuji Hospital Tokyo Japan
Latvian Association of Allergists University Children Hospital Riga Latvia
Laval University Quebec City Quebec Canada
LEADER Research Inc Hamilton Ontario Canada
Life and Health Sciences Research Institute School of Medicine University of Minho Braga Portugal
Macquarie University Macquarie Park NSW Australia
Medical Consulting Czarlewski Levallois France
Medical Faculty ENT Department Eskisehir Osmangazi University Eskisehir Turkey
Medical Faculty Skopje University Clinic of Pulmonology and Allergy Skopje Republic of Macedonia
Medical School University of Cyprus Nicosia Cyprus
Microbiology Department College of Medicine Kuwait University Kuwait City Kuwait
Mohammed Bin Rashid University Dubai Health Dubai UAE
Nova Southeastern University College of Allopathic Medicine Fort Lauderdale Florida USA
Oasi Research Institute IRCCS Troina Italy
Office of Research Metro North Hospital and Health Service Brisbane Australia
ORL SOKLIC KOSAK Ljubljana Slovenia
Otolaryngology Department General Hospital of Kalamata Kalamata Greece
Otolaryngology HNS University of Zurich University Hospital of Zurich Zurich Switzerland
Otorhinolaryngology and Neck Surgery Unit San Juan de Dios National Hospital San Miguel El Salvador
Paediatric Allergy Clinic Department of Dermatology Amersham Hospital NHS Hospital Trust Amersham UK
Pediatrics Department Faculty of Medicine Universidad Austral de Chile Valdivia Chile
Pneumologie AP HP Centre Université de Paris Cité Hôpital Cochin Paris France
Pneumology Department Hospital Universitari Dexeus Barcelona Spain
Poltava State Medical University Immunology and Allergology Department Poltava Ukraine
PROMISE Department University of Palermo Palermo Italy
Pulmonary Department Rashid Hospital DUBAI Health Dubai UAE
Pulmonary Environmental Epidemiology Unit CNR Institute of Clinical Physiology Pisa Italy
Rappaport Faculty of Medicine Technion Israel Institute of Technology Haifa Israel
Research Institute of Medical and Health Sciences University of Sharjah Sharjah UAE
Research Network Faculty of Medicine University of Porto Porto Portugal
Respiralab Research Group Guayaquil Guayas Ecuador
Respiratory and Allergy Clinic IRCCS Policlinico San Martino Genoa Italy
Respiriamo Insieme Association Asthma and Allergy Center Padova Italy
Riga East University Hospital Riga Latvia
Sach's Children and Youth Hospital Södersjukhuset Stockholm Sweden
Samitivej Allergy Institute Bangkok Thailand
School of Medicine Universidad de los Andes Bogotá DC Colombia
Scientific and Medical Department Lofarma S p A Milan Italy
Section of Allergy and Immunology Saint Louis University School of Medicine Saint Louis Missouri USA
Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina
Servicio de Alergia e Inmunología clínica Hospital Universitario de Puebla Puebla México
Serviço de Imunoalergologia Centro Hospitalar Universitário São João Porto Portugal
Serviço de Imunoalergologia Hospital de Dona Estefânia Lisbon Portugal
Shanghai Skin Disease Hospital Tongji University School of Medicine Shanghai China
Skin and Allergy Hospital Helsinki University Hospital and University of Helsinki Helsinki Finland
SOS Allergology and Clinical Immunology USL Toscana Centro Prato Italy
Swiss Institute of Allergy and Asthma Research University of Zurich Davos Switzerland
The Allergy and Asthma Institute Allergy and Asthma Department Islamabad Pakistan
The David Hide Asthma and Allergy Centre St Mary's Hospital Isle of Wight UK
UBIAir Clinical and Experimental Lung Centre University of Beira Interior Covilhã Portugal
UMR 1016 Institut Cochin Paris France
Universidad Espíritu Santo Samborondón Ecuador
Universitat Pompeu Fabra Barcelona Spain
Université Paris Cité Paris France
Université Paris Saclay UVSQ Univ Paris Sud Villejuif France
University of Liverpool Liverpool UK
Zobrazit více v PubMed
Bousquet J., Anto J. M., Bachert C., et al., “Allergic Rhinitis,” Nature Reviews. Disease Primers 6, no. 1 (2020): 95, 10.1038/s41572-020-00227-0. PubMed DOI
Maio S., Baldacci S., Carrozzi L., et al., “18‐Yr Cumulative Incidence of Respiratory/Allergic Symptoms/Diseases and Risk Factors in the Pisa Epidemiological Study,” Respiratory Medicine 158 (2019): 33–41. PubMed
Savouré M., Bousquet J., Jaakkola J. J., Jaakkola M. S., Jacquemin B., and Nadif R., “Worldwide Prevalence of Rhinitis in Adults: A Review of Definitions and Temporal Evolution,” Clinical and Translational Allergy 12, no. 3 (2022): e12130. PubMed PMC
Zuberbier T., Lotvall J., Simoens S., Subramanian S. V., and Church M. K., “Economic Burden of Inadequate Management of Allergic Diseases in the European Union: A GA(2) LEN Review,” Allergy 69, no. 10 (2014): 1275–1279, 10.1111/all.12470. PubMed DOI
Bousquet J., Van Cauwenberge P., Khaltaev N., Aria Workshop G., and World Health O., “Allergic Rhinitis and Its Impact on Asthma,” Journal of Allergy and Clinical Immunology 108, no. 5 Suppl (2001): S147–S334, 10.1067/mai.2001.118891. PubMed DOI
Brozek J. L., Bousquet J., Agache I., et al., “Allergic Rhinitis and Its Impact on Asthma (ARIA) Guidelines‐2016 Revision,” Journal of Allergy and Clinical Immunology 140, no. 4 (2017): 950–958, 10.1016/j.jaci.2017.03.050. PubMed DOI
Brozek J. L., Bousquet J., Baena‐Cagnani C. E., et al., “Allergic Rhinitis and Its Impact on Asthma (ARIA) Guidelines: 2010 Revision,” Journal of Allergy and Clinical Immunology 126, no. 3 (2010): 466–476, 10.1016/j.jaci.2010.06.047. PubMed DOI
Brignardello‐Petersen R., Carrasco‐Labra A., and Guyatt G. H., “How to Interpret and Use a Clinical Practice Guideline or Recommendation: Users' Guides to the Medical Literature,” Journal of the American Medical Association 326, no. 15 (2021): 1516–1523, 10.1001/jama.2021.15319. PubMed DOI
Bousquet J., Schunemann H. J., Togias A., et al., “Next‐Generation Allergic Rhinitis and Its Impact on Asthma (ARIA) Guidelines for Allergic Rhinitis Based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and Real‐World Evidence,” Journal of Allergy and Clinical Immunology 145, no. 1 (2020): 70–80.e3, 10.1016/j.jaci.2019.06.049. PubMed DOI
Bousquet J., Schunemann H. J., Sousa‐Pinto B., et al., “Concepts for the Development of Person‐Centered, Digitally Enabled, Artificial Intelligence‐Assisted ARIA Care Pathways (ARIA 2024),” Journal of Allergy and Clinical Immunology. In Practice 12, no. 10 (2024): 2648–2668, 10.1016/j.jaip.2024.06.040. PubMed DOI
Alonso‐Coello P., Schunemann H. J., Moberg J., et al., “GRADE Evidence to Decision (EtD) Frameworks: A Systematic and Transparent Approach to Making Well Informed Healthcare Choices. 1: Introduction,” BMJ 353 (2016): i2016, 10.1136/bmj.i2016. PubMed DOI
Alonso‐Coello P., Oxman A. D., Moberg J., et al., “GRADE Evidence to Decision (EtD) Frameworks: A Systematic and Transparent Approach to Making Well Informed Healthcare Choices. 2: Clinical Practice Guidelines,” BMJ 353 (2016): i2089, 10.1136/bmj.i2089. PubMed DOI
Bousquet J., Sousa‐Pinto B., Anto J. M., et al., “MASK‐Air: An OECD (Organisation for Economic Co‐Operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases,” Journal of Allergy and Clinical Immunology. In Practice 12, no. 8 (2024): 2010–2016, 10.1016/j.jaip.2024.03.024. PubMed DOI
Bousquet J., Schunemann H. J., Hellings P. W., et al., “MACVIA Clinical Decision Algorithm in Adolescents and Adults With Allergic Rhinitis,” Journal of Allergy and Clinical Immunology 138, no. 2 (2016): 367–374.e2, 10.1016/j.jaci.2016.03.025. PubMed DOI
Bousquet J., Anto J. M., Sousa‐Pinto B., et al., “Digitally‐Enabled, Patient‐Centred Care in Rhinitis and Asthma Multimorbidity: The ARIA‐MASK‐Air((R)) Approach,” Clinical and Translational Allergy 13, no. 1 (2023): e12215, 10.1002/clt2.12215. PubMed DOI PMC
Sousa‐Pinto B., Vieira R. J., Marques‐Cruz M., et al., “Artificial Intelligence‐Supported Development of Health Guideline Questions,” Annals of Internal Medicine 177 (2024): 1518–1529, 10.7326/ANNALS-24-00363. PubMed DOI
Finnegan P., Murphy M., and O'Connor C., “#Corticophobia: A Review on Online Misinformation Related to Topical Steroids,” Clinical and Experimental Dermatology 48, no. 2 (2023): 112–115, 10.1093/ced/llac019. PubMed DOI
Sousa‐Pinto B., Sa‐Sousa A., Vieira R. J., et al., “Behavioural Patterns in Allergic Rhinitis Medication in Europe: A Study Using MASK‐Air((R)) Real‐World Data,” Allergy 77, no. 9 (2022): 2699–2711, 10.1111/all.15275. PubMed DOI
Bousquet J., Klimek L., Kuna P., Mullol J., and Toppila‐Salmi S., “The Debate: Regular Versus As‐Needed Use of Intranasal Corticosteroids for a Patient‐Centered Approach,” Journal of Allergy and Clinical Immunology. In Practice 9, no. 3 (2021): 1374–1375, 10.1016/j.jaip.2020.11.019. PubMed DOI
Canonica G. W., Fumagalli F., Guerra L., et al., “Levocetirizine in Persistent Allergic Rhinitis: Continuous or On‐Demand Use? A Pilot Study,” Current Medical Research and Opinion 24, no. 10 (2008): 2829–2839, 10.1185/03007990802395927. PubMed DOI
Dykewicz M. S., Kaiser H. B., Nathan R. A., et al., “Fluticasone Propionate Aqueous Nasal Spray Improves Nasal Symptoms of Seasonal Allergic Rhinitis When Used as Needed (Prn),” Annals of Allergy, Asthma & Immunology 91, no. 1 (2003): 44–48, 10.1016/S1081-1206(10)62057-1. PubMed DOI
Juniper E. F., Guyatt G. H., O'Byrne P. M., and Viveiros M., “Aqueous Beclomethasone Diproprionate Nasal Spray: Regular Versus “as Required” Use in the Treatment of Seasonal Allergic Rhinitis,” Journal of Allergy and Clinical Immunology 86, no. 3 Pt 1 (1990): 380–386, 10.1016/s0091-6749(05)80101-0. PubMed DOI
Kaszuba S. M., Baroody F. M., deTineo M., Haney L., Blair C., and Naclerio R. M., “Superiority of an Intranasal Corticosteroid Compared With an Oral Antihistamine in the As‐Needed Treatment of Seasonal Allergic Rhinitis,” Archives of Internal Medicine 161, no. 21 (2001): 2581–2587, 10.1001/archinte.161.21.2581. PubMed DOI
Phinyo P., Wongsa C., Sompornrattanaphan M., and Thongngarm T., “As‐Needed Versus Regular Intranasal Corticosteroid for Allergic Rhinitis: A Systematic Review and Meta‐Analysis,” Asian Pacific Journal of Allergy and Immunology 40, no. 3 (2022): 195–204, 10.12932/AP-091121-1269. PubMed DOI
Thongngarm T., Wongsa C., Phinyo P., Assanasen P., Tantilipikorn P., and Sompornrattanaphan M., “As‐Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients With Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial,” Journal of Allergy and Clinical Immunology: In Practice 9, no. 3 (2021): 1365–1373.e6, 10.1016/j.jaip.2020.09.057. PubMed DOI
Wartna J. B., Bohnen A. M., Elshout G., et al., “Symptomatic Treatment of Pollen‐Related Allergic Rhinoconjunctivitis in Children: Randomized Controlled Trial,” Allergy 72, no. 4 (2017): 636–644, 10.1111/all.13056. PubMed DOI
Anto A., Sousa‐Pinto B., Czarlewski W., et al., “Automatic Market Research of Mobile Health Apps for the Self‐Management of Allergic Rhinitis,” Clinical and Experimental Allergy 52, no. 10 (2022): 1195–1207, 10.1111/cea.14135. PubMed DOI
Bousquet J., Bedbrook A., Czarlewski W., et al., “Guidance to 2018 Good Practice: ARIA Digitally‐Enabled, Integrated, Person‐Centred Care for Rhinitis and Asthma,” Clinical and Translational Allergy 9 (2019): 16, 10.1186/s13601-019-0252-0. PubMed DOI PMC
Sousa‐Pinto B., Eklund P., Pfaar O., et al., “Validity, Reliability, and Responsiveness of Daily Monitoring Visual Analog Scales in MASK‐Air,” Clinical and Translational Allergy 11, no. 7 (2021): e12062, 10.1002/clt2.12062. PubMed DOI PMC
Bousquet J., Sousa‐Pinto B., Anto J. M., et al., “Concurrent Validity, Cut‐Offs and Ability to Change of Patient‐Reported Outcome Measures for Rhinitis and Asthma in MASK‐Air((R)),” Clinical and Translational Allergy 14, no. 9 (2024): e12390, 10.1002/clt2.12390. PubMed DOI PMC
Vieira R. J., Sousa‐Pinto B., Cardoso‐Fernandes A., et al., “Control of Allergic Rhinitis and Asthma Test: A Systematic Review of Measurement Properties and COSMIN Analysis,” Clinical and Translational Allergy 12, no. 9 (2022): e12194, 10.1002/clt2.12194. PubMed DOI PMC
Reilly M. C., Tanner A., and Meltzer E. O., “Work, Classroom and Activity Impairment Instruments: Validation Studies in Allergic Rhinitis,” Clinical Drug Investigation 11 (1996): 278–288.
Reilly M. C., Zbrozek A. S., and Dukes E. M., “The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument,” PharmacoEconomics 4, no. 5 (1993): 353–365. PubMed
Sousa‐Pinto B., Louis G., Rodrigues J., et al., “Impairment of EQ‐5D‐5L Domains According to Allergic Rhinitis and Asthma Control: A MASK‐Air Real‐World Study,” Journal of Allergy and Clinical Immunology. In Practice 11 (2023): 3742–3751.e9, 10.1016/j.jaip.2023.08.006. PubMed DOI
Vieira R. J., Leemann L., Schunemann H. J., et al., “Impact of Uncontrolled Symptoms on the Health‐Related Quality of Life (EQ‐5D‐5L) of Patients With Allergic Rhinitis: A MASK‐Air Study,” Clinical and Experimental Allergy 54, no. 8 (2024): 634–637, 10.1111/cea.14516. PubMed DOI
Sofiev M., Palamarchuk Y., Bedard A., et al., “A Demonstration Project of Global Alliance Against Chronic Respiratory Diseases: Prediction of Interactions Between Air Pollution and Allergen Exposure‐The Mobile Airways Sentinel NetworK‐Impact of Air POLLution on Asthma and Rhinitis Approach,” Chinese Medical Journal 133, no. 13 (2020): 1561–1567, 10.1097/CM9.0000000000000916. PubMed DOI PMC
Sousa‐Pinto B., Palamarchuk Y., Leemann L., et al., “From MASK‐Air and SILAM to CATALYSE (Climate Action to Advance HeaLthY Societies in Europe),” Journal of Investigational Allergology & Clinical Immunology 34, no. 1 (2024): 12–19, 10.18176/jiaci.0923. PubMed DOI
Brozek J., Borowiack E., Sadowska E., et al., “Patients' Values and Preferences for Health States in Allergic Rhinitis‐An Artificial Intelligence Supported Systematic Review,” Allergy 79, no. 7 (2024): 1812–1830, 10.1111/all.16100. PubMed DOI
Dykewicz M. S., Wallace D. V., Amrol D. J., et al., “Rhinitis 2020: A Practice Parameter Update,” Journal of Allergy and Clinical Immunology 146, no. 4 (2020): 721–767, 10.1016/j.jaci.2020.07.007. PubMed DOI
Guyatt G. H., Oxman A. D., Kunz R., et al., “GRADE Guidelines: 2. Framing the Question and Deciding on Important Outcomes,” Journal of Clinical Epidemiology 64, no. 4 (Apr 2011): 395–400, 10.1016/j.jclinepi.2010.09.012. PubMed DOI
Schunemann H. J., Armstrong D., Degl'innocenti A., et al., “A Randomized Multicenter Trial to Evaluate Simple Utility Elicitation Techniques in Patients With Gastroesophageal Reflux Disease,” Medical Care 42, no. 11 (2004): 1132–1142, 10.1097/00005650-200411000-00013. PubMed DOI
Sousa‐Pinto B., Valiulis A., Melen E., et al., “Asthma and Rhinitis Control in Adolescents and Young Adults: A Real‐World MASK‐Air Study,” Pediatric Allergy and Immunology 35, no. 2 (2024): e14080, 10.1111/pai.14080. PubMed DOI
Taborda‐Barata L., Ventura M. T., Blain H., et al., “MASK‐Air((R)) Real‐World Data in Respiratory Allergy in Old‐Age Adults,” Clinical and Translational Allergy 13, no. 1 (2023): e12216, 10.1002/clt2.12216. PubMed DOI PMC
Rosario C. S., Cardozo C. A., Neto H. J. C., and Filho N. A. R., “Do Gender and Puberty Influence Allergic Diseases?,” Allergologia et Immunopathologia 49, no. 2 (2021): 122–125, 10.15586/aei.v49i2.49. PubMed DOI
Keller T., Hohmann C., Standl M., et al., “The Sex‐Shift in Single Disease and Multimorbid Asthma and Rhinitis During Puberty–A Study by MeDALL,” Allergy 73, no. 3 (2018): 602–614, 10.1111/all.13312. PubMed DOI PMC
Goldhahn K., Bockelbrink A., Nocon M., et al., “Sex‐Specific Differences in Allergic Sensitization to House Dust Mites: A Meta‐Analysis,” Annals of Allergy, Asthma & Immunology 102, no. 6 (2009): 487–494. PubMed
Gupta K. K. and Anari S., “Medical Management of Rhinitis in Pregnancy,” Auris, Nasus, Larynx 49, no. 6 (2022): 905–911, 10.1016/j.anl.2022.01.014. PubMed DOI
Bousquet J., Melen E., Haahtela T., et al., “Rhinitis Associated With Asthma Is Distinct From Rhinitis Alone: The ARIA‐MeDALL Hypothesis,” Allergy 78, no. 5 (2023): 1169–1203, 10.1111/all.15679. PubMed DOI
Anto J. M., Bousquet J., Akdis M., et al., “Mechanisms of the Development of Allergy (MeDALL): Introducing Novel Concepts in Allergy Phenotypes,” Journal of Allergy and Clinical Immunology 139, no. 2 (2017): 388–399, 10.1016/j.jaci.2016.12.940. PubMed DOI
Bousquet J., Sousa‐Pinto B., Regateiro F. S., et al., “MASK‐Air Direct Patient Data Support the ARIA‐MeDALL Hypothesis on Allergic Phenotypes,” Allergy 78, no. 10 (2023): 2790–2794, 10.1111/all.15842. PubMed DOI
Bousquet J., Devillier P., Anto J. M., et al., “Daily Allergic Multimorbidity in Rhinitis Using Mobile Technology: A Novel Concept of the MASK Study,” Allergy 73, no. 8 (2018): 1622–1631, 10.1111/all.13448. PubMed DOI
Cibella F., Ferrante G., Cuttitta G., et al., “The Burden of Rhinitis and Rhinoconjunctivitis in Adolescents,” Allergy, Asthma & Immunology Research 7, no. 1 (2015): 44–50, 10.4168/aair.2015.7.1.44. PubMed DOI PMC
Burte E., Bousquet J., Siroux V., Just J., Jacquemin B., and Nadif R., “The Sensitization Pattern Differs According to Rhinitis and Asthma Multimorbidity in Adults: The EGEA Study,” Clinical and Experimental Allergy 47, no. 4 (2017): 520–529, 10.1111/cea.12897. PubMed DOI
Siroux V., Boudier A., Nadif R., Lupinek C., Valenta R., and Bousquet J., “Association Between Asthma, Rhinitis, and Conjunctivitis Multimorbidities With Molecular IgE Sensitization in Adults,” Allergy 74, no. 4 (2019): 824–827, 10.1111/all.13676. PubMed DOI
Amaral R., Bousquet J., Pereira A. M., et al., “Disentangling the Heterogeneity of Allergic Respiratory Diseases by Latent Class Analysis Reveals Novel Phenotypes,” Allergy 74, no. 4 (2019): 698–708, 10.1111/all.13670. PubMed DOI
Raciborski F., Bousquet J., Bousqet J., et al., “Dissociating Polysensitization and Multimorbidity in Children and Adults From a Polish General Population Cohort,” Clinical and Translational Allergy 9 (2019): 4, 10.1186/s13601-019-0246-y. PubMed DOI PMC
Neumann I., Anto J. M., Bousquet J., and Schunemann H. J., “The Impact of Climate Change on Health Needs Structured Evidence Assessment and an Evidence to Action Framework to Make Decisions: A Proposal to Adopt the GRADE Approach,” Journal of Clinical Epidemiology 157 (2023): 146–153, 10.1016/j.jclinepi.2023.01.006. PubMed DOI
Chu D. K., Brignardello‐Petersen R., Guyatt G. H., Ricci C., and Genuneit J., “Method's Corner: Allergist's Guide to Network Meta‐Analysis,” Pediatric Allergy and Immunology 33, no. 1 (2022): e13609, 10.1111/pai.13609. PubMed DOI
Sousa‐Pinto B., Vieira R. J., Bognanni A., et al., “Efficacy and Safety of Intranasal Medications for Allergic Rhinitis: Network Meta‐Analysis,” Allergy 80, no. 1 (2025): 94–105. PubMed
Sousa‐Pinto B., Vieira R. J., Brozek J., et al., “Intranasal Antihistamines and Corticosteroids in Allergic Rhinitis: A Systematic Review and Meta‐Analysis,” Journal of Allergy and Clinical Immunology 154, no. 2 (2024): 340–354, 10.1016/j.jaci.2024.04.016. PubMed DOI
Torres M. I., Gil‐Mata S., Bognanni A., et al., “Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta‐Analysis,” Journal of Allergy and Clinical Immunology. In Practice 12 (2024): 3404–3418, 10.1016/j.jaip.2024.09.001. PubMed DOI
Sousa‐Pinto B., Vieira R. J., Brozek J., et al., “Intranasal Antihistamines and Corticosteroids in the Treatment of Allergic Rhinitis: A Systematic Review and Meta‐Analysis Protocol,” BMJ Open 13, no. 11 (2023): e076614, 10.1136/bmjopen-2023-076614. PubMed DOI PMC
Vieira R. J., Torres M. I., Bognanni A., et al., “Protocol for the Systematic Reviews on the Desirable and Undesirable Effects of Pharmacological Treatments of Allergic Rhinitis Informing the ARIA 2024 Guidelines,” Allergol Select 8 (2024): 270–277, 10.5414/ALX02515E. PubMed DOI PMC
Kostis J. B. and Dobrzynski J. M., “Limitations of Randomized Clinical Trials,” American Journal of Cardiology 129 (2020): 109–115, 10.1016/j.amjcard.2020.05.011. PubMed DOI
Tsang R., Colley L., and Lynd L. D., “Inadequate Statistical Power to Detect Clinically Significant Differences in Adverse Event Rates in Randomized Controlled Trials,” Journal of Clinical Epidemiology 62, no. 6 (2009): 609–616, 10.1016/j.jclinepi.2008.08.005. PubMed DOI
Centre U. M., “About VigiBase,” https://who‐umc.org/vigibase/.
Rothman K. J., Lanes S., and Sacks S. T., “The Reporting Odds Ratio and Its Advantages Over the Proportional Reporting Ratio,” Pharmacoepidemiology and Drug Safety 13, no. 8 (2004): 519–523, 10.1002/pds.1001. PubMed DOI
Vieira R. J., Sousa‐Pinto B., Bognanni A., et al., “Embedding Patients' Values and Preferences in Guideline Development for Allergic Diseases: The Case Study of Allergic Rhinitis and Its Impact on Asthma 2024,” Clinical and Translational Allergy 14, no. 6 (2024): e12377, 10.1002/clt2.12377. PubMed DOI PMC
Vieira R. J., Leemann L., Briggs A., et al., “Poor Rhinitis and Asthma Control Is Associated With Decreased Health‐Related Quality of Life and Utilities: A MASK‐Air Study,” Journal of Allergy and Clinical Immunology. In Practice 12, no. 6 (Jun 2024): 1530–1538 e6, 10.1016/j.jaip.2024.03.036. PubMed DOI
Gil‐Mata S., Teixeira T., Bedbrook A., et al., “Perceptions of the Impact of Individual Allergic Rhinitis Symptoms: A Survey of ARIA Clinical Experts,” World Allergy Organization Journal 17, no. 12 (2024): 100999, 10.1016/j.waojou.2024.100999. PubMed DOI PMC
Vieira R. J., Azevedo L. F., Pereira A. M., et al., “Impact of Allergic Rhinitis Control on Work Productivity and Costs: A Real‐World Data MASK‐Air Study,” Journal of Allergy and Clinical Immunology. In Practice 12 (2024): 3107–3115.e13, 10.1016/j.jaip.2024.07.026. PubMed DOI
Health CAfDaTi , CDR Pharmacoeconomic Review Report for Dymista (2016), https://www.cda‐amc.ca/sites/default/files/cdr/pharmacoeconomic/SR0408_Dymista_PE_Report.pdf.
World Health Organization , The Selection and Use of Essential Medicines: Report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2023 (Including the 23rd WHO Model List of Essential Medicines and the 9th WHO Model List of Essential Medicines for Children) (World Health Organization, 2024).
Shikiar R. and Rentz A. M., “Satisfaction With Medication: An Overview of Conceptual, Methodologic, and Regulatory Issues,” Value in Health 7, no. 2 (2004): 204–215, 10.1111/j.1524-4733.2004.72252.x. PubMed DOI
Sousa‐Pinto B., Schunemann H. J., Sa‐Sousa A., et al., “Comparison of Rhinitis Treatments Using MASK‐Air(R) Data and Considering the Minimal Important Difference,” Allergy 77, no. 10 (2022): 3002–3014, 10.1111/all.15371. PubMed DOI
Menditto E., Costa E., Midao L., et al., “Adherence to Treatment in Allergic Rhinitis Using Mobile Technology the MASK Study,” Clinical and Experimental Allergy 49, no. 4 (2019): 442–460, 10.1111/cea.13333. PubMed DOI
Sousa‐Pinto B., Costa E. M., Vieira R. J., et al., “Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐Air Study,” Clinical and Experimental Allergy 55 (2025): 226–238, 10.1111/cea.70004. PubMed DOI PMC
European Medicines Agency , Guideline on the Clinical Development of Medicinal Products for the Treatment of Allergic Rhinoconjunctivitis (2004).
Whitmee S., Haines A., Beyrer C., et al., “Safeguarding Human Health in the Anthropocene Epoch: Report of the Rockefeller Foundation–Lancet Commission on Planetary Health,” Lancet 386, no. 10007 (2015): 1973–2028. PubMed
Herrmann A., Lenzer B., Müller B. S., et al., “Integrating Planetary Health Into Clinical Guidelines to Sustainably Transform Health Care,” Lancet Planetary Health 6, no. 3 (2022): e184–e185. PubMed
Bousquet J., Anto J. M., Haahtela T., et al., “Digital Transformation of Health and Care to Sustain Planetary Health: The MASK Proof‐of‐Concept for Airway Diseases‐POLLAR Symposium Under the Auspices of Finland's Presidency of the EU, 2019 and MACVIA‐France, Global Alliance Against Chronic Respiratory Diseases (GARD, WH0) Demonstration Project, Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing,” Clinical and Translational Allergy 10 (2020): 24, 10.1186/s13601-020-00321-2. PubMed DOI PMC
Halonen J. I., Erhola M., Furman E., et al., “The Helsinki Declaration 2020: Europe That Protects,” Lancet Planetary Health 4, no. 11 (2020): e503–e505, 10.1016/S2542-5196(20)30242-4. PubMed DOI
Halonen J. I., Erhola M., Furman E., et al., “A Call for Urgent Action to Safeguard Our Planet and Our Health in Line With the Helsinki Declaration,” Environmental Research 193 (2021): 110600, 10.1016/j.envres.2020.110600. PubMed DOI
Andrews J., Guyatt G., Oxman A. D., et al., “GRADE Guidelines: 14. Going From Evidence to Recommendations: The Significance and Presentation of Recommendations,” Journal of Clinical Epidemiology 66, no. 7 (2013): 719–725, 10.1016/j.jclinepi.2012.03.013. PubMed DOI
Andrews J. C., Schunemann H. J., Oxman A. D., et al., “GRADE Guidelines: 15. Going From Evidence to Recommendation‐Determinants of a Recommendation's Direction and Strength,” Journal of Clinical Epidemiology 66, no. 7 (2013): 726–735, 10.1016/j.jclinepi.2013.02.003. PubMed DOI
Courbis A. L., Murray R. B., Arnavielhe S., et al., “Electronic Clinical Decision Support System for Allergic Rhinitis Management: MASK e‐CDSS,” Clinical and Experimental Allergy 48, no. 12 (2018): 1640–1653, 10.1111/cea.13230. PubMed DOI
Schünemann H. J., Al‐Ansary L. A., Forland F., et al., “Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines,” Annals of Internal Medicine 163, no. 7 (2015): 548–553. PubMed